"Cardioprotection and Safety of Dexrazoxane in Patients Treated for Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Advanced-Stage Lymphoblastic Non-Hodgkin Lymphoma: A Report of the Children's Oncology Group Randomized Trial Pediatric Oncology Group 9404," (vol 34, pg 854, 2016)

被引：0
|
作者：
Asselin, Barbara L.
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 18期
关键词：
D O I：
10.1200/JCO.2017.73.9433
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2100 / 2100
页数：1
相关论文
共 50 条
  • [21] Nelarabine May Be Safely Incorporated Into a Phase III Study for Newly Diagnosed T-Lineage Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group
    Winter, Stuart S.
    Devidas, Meenakshi
    Wood, Brent
    Borowitz, Michael J.
    Loh, Mignon L.
    Asselin, Barbara
    Murphy, John
    Raetz, Elizabeth
    Winick, Naomi
    Hunger, Stephen
    Carroll, William
    Dunsmore, Kimberly
    BLOOD, 2010, 116 (21) : 378 - 378
  • [22] Pilot Study of Nelarabine in Combination With Intensive Chemotherapy in High-Risk T-Cell Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group
    Dunsmore, Kimberly P.
    Devidas, Meenakshi
    Linda, Stephen B.
    Borowitz, Michael J.
    Winick, Naomi
    Hunger, Stephen P.
    Carroll, William L.
    Camitta, Bruce M.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (22) : 2753 - 2759
  • [23] Rituximab therapy for patients with newly diagnosed, advanced-stage, follicular grade I non-Hodgkin's lymphoma: A phase II trial in the north central cancer treatment group
    Witzig, TE
    Vukov, AM
    Habermann, TM
    Geyer, S
    Kurtin, PJ
    Friedenberg, WR
    White, WL
    Chalchal, HI
    Flynn, PJ
    Fitch, TR
    Welker, DA
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (06) : 1103 - 1108
  • [24] High Immunoproteasome Expression As Indicator for Sensitivity to Bortezomib-Containing Chemotherapy in Newly Diagnosed, Standard and Intermediate Risk, T-Cell Acute Lymphoblastic Leukemia Patients from Children's Oncology Group Trial AALL1231
    Roeten, Margot S. F.
    van Meerloo, Johan
    Kwidama, Zinia
    Jenkins, Gaye
    van Dijk, Suzanne N.
    Teachey, David T.
    Devidas, Meenakshi
    Loh, Mignon L.
    Kaspers, Gertjan J. L.
    Zweegman, Sonja
    Jansen, Gerrit
    Cloos, Jacqueline
    Horton, Terzah M.
    BLOOD, 2022, 140 : 9183 - 9184
  • [25] The expression and function of Pgp, MRP1 and LRP in pediatric acute lymphoblastic leukemia (ALL): A retrospective study of 297 newly diagnosed patients by the Children's Oncology Group.
    Olson, DP
    Taylor, BJ
    Reaman, G
    Sather, H
    Ivy, SP
    BLOOD, 2000, 96 (11) : 825A - 825A
  • [26] Cranial Radiation Can be Eliminated in Most Children with T-Cell Acute Lymphoblastic Leukemia (T-ALL) and Bortezomib Potentially Improves Survival in Children with T-Cell Lymphoblastic Lymphoma (T-LL): Results of Children's Oncology Group (COG) Trial AALL1231
    Teachey, David T.
    Devidas, Meenakshi
    Wood, Brent L.
    Chen, Zhiguo
    Hayashi, Robert James
    Annett, Robert D.
    Asselin, Barbara L.
    August, Keith J.
    Cho, Steve Y.
    Dunsmore, Kimberly P.
    Fisher, Brian T.
    Freedman, Jason L.
    Galardy, Paul J.
    Harker-Murray, Paul
    Hermiston, Michelle L.
    Horton, Terzah M.
    Jaju, Alok I.
    Lam, Allison
    Messinger, Yoav H.
    Miles, Rodney R.
    Okada, Maki
    Patel, Samir I.
    Schafer, Eric S.
    Schechter-Finkelstein, Tal
    Shimano, Kristin A.
    Singh, Neelam
    Steele, Amii C.
    Sulis, Maria L.
    Vargas, Sarah L.
    Winter, Stuart S.
    Wood, Charlotte
    McKay, Patrick Zweider
    Bollard, Catherine M.
    Loh, Mignon L.
    Hunger, Stephen P.
    Raetz, Elizabeth A.
    BLOOD, 2020, 136
  • [27] CDC4 and NOTCH1 mutations in childhood T-Cell acute lymphoblastic leukemia and T cell non-Hodgkin's lymphoma; a Japan Association of Childhood Leukemia Study Group
    Park, Myoung-ja
    Taki, Tomohiko
    Suzuki, Nobuhiro
    Oda, Megumi
    Yagi, Keiko
    Kobayashi, Ryoji
    Hara, Juniti
    Horize, Keizo
    Hayashi, Yasuhide
    BLOOD, 2007, 110 (11) : 779A - 779A
  • [28] The impact of NOTCH1, FBW7 and PTEN mutations on prognosis and downstream signaling in pediatric T-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group
    A Larson Gedman
    Q Chen
    S Kugel Desmoulin
    Y Ge
    K LaFiura
    C L Haska
    C Cherian
    M Devidas
    S B Linda
    J W Taub
    L H Matherly
    Leukemia, 2009, 23 : 1417 - 1425
  • [29] The impact of NOTCH1, FBW7 and PTEN mutations on prognosis and downstream signaling in pediatric T-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group
    Gedman, A. Larson
    Chen, Q.
    Desmoulin, S. Kugel
    Ge, Y.
    LaFiura, K.
    Haska, C. L.
    Cherian, C.
    Devidas, M.
    Linda, S. B.
    Taub, J. W.
    Matherly, L. H.
    LEUKEMIA, 2009, 23 (08) : 1417 - 1425
  • [30] A Study of Rituximab and Ifosfamide, Carboplatin, and Etoposide Chemotherapy in Children with Recurrent/Refractory B-Cell (CD20+) Non-Hodgkin Lymphoma and Mature B-Cell Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group
    Griffin, Timothy C.
    Weitzman, Sheila
    Weinstein, Howard
    Chang, Myron
    Cairo, Mitchell
    Hutchison, Robert
    Shiramizu, Bruce
    Wiley, Joseph
    Woods, Deborah
    Barnich, Margaret
    Gross, Thomas G.
    PEDIATRIC BLOOD & CANCER, 2009, 52 (02) : 177 - 181
12345